Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice is a research paper published in Viruses (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: U19AI171401
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: 441019/2020-0
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: 307162/2017-6
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: E-26/210.182/2020
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: E-26/201.067/2021
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: E-26/210.112/2020
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: 88887.506989/2020-00
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: 465313/2014-0
National Institutes of Health
Grant: 1U19AI171401-01
Metropolitan AntiViral Drug Accelerator
NIH HHS
Grant: 2U19AI171401-01A1
FWCI
0.92
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords